Healthcare -
Biotechnology - NASDAQ - US
$ 14.52
-6.02 %
$ 1.1 B
Market Cap
-5.04
P/E
NRIX - STOCK-BASED COMPENSATION
Stock-based Compensation NRIX - Nurix Therapeutics, Inc.
33.9 M
LAST VALUE
9.82%
2 YEAR CAGR
131.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR